Cargando…

Low GAS5 expression may predict poor survival and cisplatin resistance in cervical cancer

Cisplatin resistance is a major challenge in cervical cancer (CC) chemotherapy. Growth arrest‐specific 5 (GAS5) has been reported to be a tumour suppressor gene in CC. However, the mechanism of GAS5 in chemoresistance remains undetermined. Our research evaluated GAS5 expression in normal and CC tiss...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fang, Xingyu, Zhong, Guanglei, Wang, Yuhan, Lin, Zhongqiu, Lin, Rongchun, Yao, Tingting
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7359315/ https://www.ncbi.nlm.nih.gov/pubmed/32661236 http://dx.doi.org/10.1038/s41419-020-2735-2

Ejemplares similares

Long non-coding RNA AK001903 regulates tumor progression in cervical cancer
por: Zhong, Guanglei, et al.
Publicado: (2021)

HPV-specific risk assessment of cervical cytological abnormalities
por: Zhong, Guanglei, et al.
Publicado: (2021)

Pembrolizumab in FIGO IVB Verrucous Carcinoma of the Vulva: A Case Report
por: Wang, Yuhan, et al.
Publicado: (2021)

ALDH-1-positive cells exhibited a radioresistant phenotype that was enhanced with hypoxia in cervical cancer
por: Yao, Tingting, et al.
Publicado: (2020)

Downregulation of long noncoding RNA MEG3 is associated with poor prognosis and promoter hypermethylation in cervical cancer
por: Zhang, Jun, et al.
Publicado: (2017)

CircCASC15-miR-100-mTOR may influence the cervical cancer radioresistance
por: Yao, Tingting, et al.
Publicado: (2022)

Survival, treatment pattern, and treatment outcome in patients with cervical cancer metastatic to distant lymph nodes
por: Lin, Haoliang, et al.
Publicado: (2022)

The expression of ALDH1 in cervical carcinoma
por: Yao, Tingting, et al.
Publicado: (2011)

TGF-β signaling promotes cervical cancer metastasis via CDR1as
por: Zhong, Guanglei, et al.
Publicado: (2023)

Low GAS5 Levels as a Predictor of Poor Survival in Patients with Lower-Grade Gliomas
por: Wang, Yanfang, et al.
Publicado: (2019)

Aberrant Methylation of MEG3 Functions as a Potential Plasma-Based Biomarker for Cervical Cancer
por: Zhang, Jun, et al.
Publicado: (2017)

Positive crosstalk between EGFR and the TF-PAR2 pathway mediates resistance to cisplatin and poor survival in cervical cancer
por: Hugo de Almeida, Vitor, et al.
Publicado: (2018)

High Expression of CCDC34 Is Associated with Poor Survival in Cervical Cancer Patients
por: Liu, Lian-Bin, et al.
Publicado: (2018)

Development and Validation of a Nomogram to Predict the Probability of Venous Thromboembolism in Patients with Epithelial Ovarian Cancer
por: Wang, Yuhan, et al.
Publicado: (2022)

Exploration of tumor-suppressive microRNAs silenced by DNA hypermethylation in cervical cancer
por: Yao, Tingting, et al.
Publicado: (2013)

VX680 suppresses the growth of HepG2 cells and enhances the chemosensitivity to cisplatin
por: YAO, RUCHENG, et al.
Publicado: (2014)

N(6)-Methyladenosine Associated Silencing of miR-193b Promotes Cervical Cancer Aggressiveness by Targeting CCND1
por: Huang, Chunxian, et al.
Publicado: (2021)

Can pelvic lymphadenectomy be omitted in patients with stage IA2, IB1, and IIA1 squamous cell cervical cancer?
por: Wang, Yaxian, et al.
Publicado: (2016)

β-Catenin Expression Negatively Correlates with WIF1 and Predicts Poor Clinical Outcomes in Patients with Cervical Cancer
por: Liang, Jinxiao, et al.
Publicado: (2016)

HPIP: a predictor of lymph node metastasis and poor survival in cervical cancer
por: Cao, Shan, et al.
Publicado: (2017)

Downregulation of RPL15 may predict poor survival and associate with tumor progression in pancreatic ductal adenocarcinoma
por: Yan, Ting-Ting, et al.
Publicado: (2015)

Bcl-2 confers survival in cisplatin treated cervical cancer cells: circumventing cisplatin dose-dependent toxicity and resistance
por: Leisching, Gina, et al.
Publicado: (2015)

DSG2 expression is low in colon cancer and correlates with poor survival
por: Yang, Tingting, et al.
Publicado: (2021)

LINC00963 May Be Associated with a Poor Prognosis in Patients with Cervical Cancer
por: Chang, Aimin, et al.
Publicado: (2022)

Upregulation of homeobox gene is correlated with poor survival outcomes in cervical cancer
por: Eoh, Kyung Jin, et al.
Publicado: (2017)

The Glasgow Prognostic Score Predicts Poor Survival in Cisplatin-Based Treated Patients with Metastatic Nasopharyngeal Carcinoma
por: Chen, Cui, et al.
Publicado: (2014)

A high IL6/IL17 ratio combined with low IL5 expression is correlated with poor survival in squamous cervical cancer
por: Punt, Simone, et al.
Publicado: (2014)

Radiosensitizers in cervical cancer. Cisplatin and beyond
por: Candelaria, Myrna, et al.
Publicado: (2006)

Retreatment with Cisplatin May Provide a Survival Advantage for Children with Relapsed/Refractory Hepatoblastoma: An Institutional Experience
por: Somers, Katherine M., et al.
Publicado: (2023)

Sonophoresis Enhanced Transdermal Delivery of Cisplatin in the Xenografted Tumor Model of Cervical Cancer
por: Ma, Shanshan, et al.
Publicado: (2020)

Combination of Sodium Cantharidinate with Cisplatin Synergistically Hampers Growth of Cervical Cancer
por: Chen, Xiangxun, et al.
Publicado: (2021)

HOTTIP Predicts Poor Survival in Gastric Cancer Patients and Contributes to Cisplatin Resistance by Sponging miR-216a-5p
por: Zhao, Rui, et al.
Publicado: (2020)

Decreased Expression of NUSAP1 Predicts Poor Overall Survival in Cervical Cancer
por: Xie, Qiqi, et al.
Publicado: (2020)

ADGRG1 Is a Predictor of Chemoresistance and Poor Survival in Cervical Squamous Carcinoma
por: Zhang, Shuo, et al.
Publicado: (2021)

High expression of CXCR4 may predict poor survival in resected pancreatic adenocarcinoma
por: Maréchal, R, et al.
Publicado: (2009)

High expression of CXCR4 may predict poor survival in resected pancreatic adenocarcinoma
por: Maréchal, R, et al.
Publicado: (2010)

Treatment of poorly differentiated neuroendocrine tumours with etoposide and cisplatin
por: Mitry, E, et al.
Publicado: (1999)

Low expression of TFPI-2 associated with poor survival outcome in patients with breast cancer
por: Xu, Cheng, et al.
Publicado: (2013)

Molecular mechanisms of cisplatin resistance in cervical cancer
por: Zhu, Haiyan, et al.
Publicado: (2016)

Co-Overexpression of GRK5/ACTC1 Correlates With the Clinical Parameters and Poor Prognosis of Epithelial Ovarian Cancer
por: Liu, Longyang, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_4ff6bcp5mmrsfvv3mhrfcpt467